drugset / Trial / NCT01192113

Safety and Efficacy of Mecobalamin Injection in Peripheral Neuropathies Patients (Study JGAZSY091109)

NCT01192113

Phase 4 Completed 1072 enrolled Eisai Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

This is an open-label, randomized, multi-center clinical trial to evaluate the safety and efficacy in peripheral neuropathies patients treated with Mecobalamin Injection

Timeline

Start
2010-04
Primary completion
2011-05
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Subject methylcobalamin Small molecule 0.5 mg/ml Intravenous

Indications